ALLAN FAIRCLOTH: Open Payments
NPI 1457876591 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,142 in 61 payments from 13 companies in 2025. Trend: 2023 $1,875 · 2024 $2,286 · 2025 $1,142
Food & beverage: $1,142
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 18 | $275 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $194 |
| Lundbeck LLC | 8 | $135 |
| Neurocrine BioSciences, Inc. | 4 | $116 |
| E.R. Squibb & Sons, L.L.C. | 5 | $102 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| Braeburn Inc. | 3 | $68 |
| Indivior Inc. | 2 | $51 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
Products named: ARISTADA, CAPLYTA, REXULTI, INGREZZA, COBENFY, BRIXADI, ABILIFY MAINTENA, SUBLOCADE.
Industry payments across NC — which companies pay providers there.
